SI1322592T1 - Substituirani 1-aminobutan-3-olni derivati - Google Patents

Substituirani 1-aminobutan-3-olni derivati

Info

Publication number
SI1322592T1
SI1322592T1 SI200130184T SI200130184T SI1322592T1 SI 1322592 T1 SI1322592 T1 SI 1322592T1 SI 200130184 T SI200130184 T SI 200130184T SI 200130184 T SI200130184 T SI 200130184T SI 1322592 T1 SI1322592 T1 SI 1322592T1
Authority
SI
Slovenia
Prior art keywords
aminobutan
derivatives
substituted
Prior art date
Application number
SI200130184T
Other languages
English (en)
Inventor
Helmut Buschmann
Corinna Maul
Bernd Sundermann
Utz-Peter Jagusch
Michael Haurand
Boris Chizh
Original Assignee
Grnenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7658871&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1322592(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grnenthal Gmbh filed Critical Grnenthal Gmbh
Publication of SI1322592T1 publication Critical patent/SI1322592T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
SI200130184T 2000-09-29 2001-09-28 Substituirani 1-aminobutan-3-olni derivati SI1322592T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10049483A DE10049483A1 (de) 2000-09-29 2000-09-29 Substituierte 1-Aminobutan-3-ol-Derivate
EP01969791A EP1322592B2 (de) 2000-09-29 2001-09-28 Substituierte 1-aminobutan-3-ol-derivate
PCT/EP2001/011231 WO2002028817A1 (de) 2000-09-29 2001-09-28 Substituierte 1-aminobutan-3-ol-derivate

Publications (1)

Publication Number Publication Date
SI1322592T1 true SI1322592T1 (sl) 2005-02-28

Family

ID=7658871

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200130184T SI1322592T1 (sl) 2000-09-29 2001-09-28 Substituirani 1-aminobutan-3-olni derivati
SI200130189T SI1322593T1 (sl) 2000-09-29 2001-09-28 O-Substituirani 6-metil-tramadolni derivati

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200130189T SI1322593T1 (sl) 2000-09-29 2001-09-28 O-Substituirani 6-metil-tramadolni derivati

Country Status (29)

Country Link
US (2) US7022739B2 (sl)
EP (2) EP1322592B2 (sl)
JP (2) JP2004509939A (sl)
KR (2) KR100835549B1 (sl)
CN (2) CN1478067A (sl)
AR (1) AR034158A1 (sl)
AT (2) ATE272045T1 (sl)
AU (4) AU2002220578B2 (sl)
BR (2) BR0114380A (sl)
CA (2) CA2423860A1 (sl)
DE (3) DE10049483A1 (sl)
DK (2) DK1322592T4 (sl)
EC (2) ECSP034530A (sl)
ES (2) ES2225605T5 (sl)
HK (2) HK1052924B (sl)
HU (2) HUP0303361A3 (sl)
IL (2) IL155106A0 (sl)
MX (2) MXPA03002737A (sl)
NO (2) NO20031382L (sl)
NZ (2) NZ524976A (sl)
PE (1) PE20020413A1 (sl)
PL (2) PL361382A1 (sl)
PT (2) PT1322592E (sl)
RU (2) RU2288219C2 (sl)
SI (2) SI1322592T1 (sl)
SK (2) SK3382003A3 (sl)
TR (2) TR200402030T4 (sl)
WO (2) WO2002026694A1 (sl)
ZA (2) ZA200303220B (sl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
DE60213116T2 (de) 2001-10-16 2007-02-08 Endo Pharmaceuticals Inc. Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung
BR0306811A (pt) * 2002-01-11 2004-10-26 Sankyo Co Composto, éster farmacologicamente aceitável do mesmo, composição farmacêutica e métodos para prevenção ou tratamento de doenças autoimunes, da artrite reumatóide e da rejeição causada pelo transplante de vários órgãos em um mamìfero
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
HUE033042T2 (en) * 2002-11-22 2017-11-28 Gruenenthal Gmbh Combination of selected analgesics with COX II inhibitors
AU2005215320B2 (en) 2004-02-24 2008-04-17 Sankyo Company, Limited Amino alcohol compound
US8669291B2 (en) * 2007-05-31 2014-03-11 Sunovion Pharmaceuticals Inc. Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
US20100183600A1 (en) * 2008-12-05 2010-07-22 Arqule, Inc. RAF Inhibitors and Their Uses
ES2343050B1 (es) * 2008-12-16 2011-06-14 Chemo Iberica, S.A. Procedimiento para la preparacion de desvenlafaxina y sus sales de adicion de acido farmaceuticamente aceptables.
WO2012100423A1 (en) 2011-01-27 2012-08-02 Eli Lilly And Company Analgesic compounds, methods, and formulations
JP2019502761A (ja) * 2016-01-21 2019-01-31 ラボラトリオス レヴィ エセエレ （（ｒ）−３−［（−１−メチルピロリジン−２−イル）メチル］−５−（２−フェニルスルホニルエチル）−１ｈ−インドールを作製する方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
ZA732238B (en) * 1972-04-06 1974-01-30 American Home Prod Benzylamine analgesics
US4155935A (en) * 1973-03-26 1979-05-22 American Home Products Corporation Benzylamine analgesics
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
US6017963A (en) * 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
DE19547766A1 (de) 1995-12-20 1997-06-26 Gruenenthal Gmbh 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-verbindungen als pharmazeutische Wirkstoffe
DE19601744C2 (de) 1996-01-19 1998-04-16 Gruenenthal Gmbh Verfahren zur Herstellung der Enantiomeren von O-Demethyltramadol
DE19609847A1 (de) † 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe
US5919826A (en) * 1996-10-24 1999-07-06 Algos Pharmaceutical Corporation Method of alleviating pain
US6245804B1 (en) * 1997-05-30 2001-06-12 Schering Aktiengesellschaft Nonsteroidal gestagens
CN1151122C (zh) * 1997-07-15 2004-05-26 拉辛斯基有限公司 反胺苯环醇及其盐以及它们的制备方法
JP2002516302A (ja) * 1998-05-22 2002-06-04 マリンクロッド・インコーポレイテッド （ｒ＊，ｒ＊）−２−［（ジメチルアミノ）メチル］−１−（３−メトキシフェニル）シクロヘキサノール塩酸塩の改良合成および精製
ES2141688B1 (es) * 1998-11-06 2001-02-01 Vita Invest Sa Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
DE19915601A1 (de) * 1999-04-07 2000-10-19 Gruenenthal Gmbh 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
WO2001013904A2 (en) * 1999-08-20 2001-03-01 Ortho-Mcneil Pharmaceutical, Inc. Composition comprising a tramadol material and an anticonvulsant drug
PE20010623A1 (es) * 1999-10-05 2001-07-07 Gruenenthal Chemie Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
US6339105B1 (en) * 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
DE10000312A1 (de) * 2000-01-05 2001-07-12 Gruenenthal Gmbh Substituierte Aminomethyl-Phenyl-Cyclohexanderivate
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
DE10048714A1 (de) * 2000-09-30 2002-04-11 Gruenenthal Gmbh 5-Amino-1-penlen-3-ol-Derivate
US6649783B2 (en) * 2001-10-03 2003-11-18 Euro-Celtique, S.A. Synthesis of (+/-)-2-((dimethylamino)methyl)-1-(aryl)cyclohexanols
AU2002364517A1 (en) * 2001-11-30 2003-06-17 Sepracor Inc. Tramadol analogs and uses thereof

Also Published As

Publication number Publication date
CN1478067A (zh) 2004-02-25
TR200402230T4 (tr) 2004-10-21
PT1322592E (pt) 2004-12-31
HUP0303195A3 (en) 2007-03-28
US6828345B2 (en) 2004-12-07
SK3402003A3 (en) 2003-09-11
KR100864796B1 (ko) 2008-10-23
KR20030059160A (ko) 2003-07-07
WO2002026694A1 (de) 2002-04-04
US7022739B2 (en) 2006-04-04
HK1052924A1 (en) 2003-10-03
ES2225605T3 (es) 2005-03-16
DE10049483A1 (de) 2002-05-02
PT1322593E (pt) 2004-12-31
DK1322593T3 (da) 2004-10-11
US20030216393A1 (en) 2003-11-20
IL155106A0 (en) 2003-10-31
ATE272045T1 (de) 2004-08-15
NZ525171A (en) 2006-02-24
ZA200303214B (en) 2004-08-31
HUP0303361A3 (en) 2007-03-28
HK1052924B (zh) 2005-03-24
CN100391933C (zh) 2008-06-04
DK1322592T4 (da) 2009-10-12
KR20030077531A (ko) 2003-10-01
DE50103036D1 (de) 2004-09-02
TR200402030T4 (tr) 2004-09-21
ECSP034532A (es) 2003-05-26
WO2002028817A1 (de) 2002-04-11
ECSP034530A (es) 2003-05-26
US20030220389A1 (en) 2003-11-27
MXPA03002737A (es) 2004-01-26
HK1052925A1 (en) 2003-10-03
EP1322593A1 (de) 2003-07-02
BR0114381A (pt) 2003-12-30
MXPA03002738A (es) 2004-01-26
HUP0303195A2 (hu) 2003-12-29
SK3382003A3 (en) 2003-08-05
NO20031387D0 (no) 2003-03-26
KR100835549B1 (ko) 2008-06-09
RU2288219C2 (ru) 2006-11-27
RU2286334C2 (ru) 2006-10-27
ES2225628T3 (es) 2005-03-16
IL155105A0 (en) 2003-10-31
AU8993701A (en) 2002-04-15
DK1322592T3 (da) 2004-11-22
ZA200303220B (en) 2004-08-19
EP1322592B1 (de) 2004-07-28
NO20031387L (no) 2003-05-21
ATE272046T1 (de) 2004-08-15
SK286727B6 (sk) 2009-04-06
AU2001289937B2 (en) 2007-01-18
NO20031382D0 (no) 2003-03-26
JP2004510755A (ja) 2004-04-08
HK1052925B (zh) 2005-04-01
CA2423903A1 (en) 2003-03-27
EP1322593B1 (de) 2004-07-28
PE20020413A1 (es) 2002-05-18
AU2057802A (en) 2002-04-08
JP2004509939A (ja) 2004-04-02
CN1466567A (zh) 2004-01-07
AU2002220578B2 (en) 2006-11-30
ES2225605T5 (es) 2009-11-18
AR034158A1 (es) 2004-02-04
PL361632A1 (en) 2004-10-04
EP1322592A1 (de) 2003-07-02
NZ524976A (en) 2005-01-28
PL361382A1 (en) 2004-10-04
HUP0303361A2 (hu) 2004-03-01
SI1322593T1 (sl) 2004-12-31
BR0114380A (pt) 2003-12-30
CA2423860A1 (en) 2003-03-27
NO20031382L (no) 2003-05-16
EP1322592B2 (de) 2009-06-17
DE50103035D1 (de) 2004-09-02

Similar Documents

Publication Publication Date Title
EG22695A (en) Novel phenyl-propargylether derivatives
HUP0301330A3 (en) 2-aminocarbonyl-9h-purine derivatives
HRP20030055A2 (en) 4-phenyl-pyridine derivatives
IL150841A0 (en) 1h-imidazopyridine derivatives
DZ3293A1 (fr) Arylpyrazines substitues
AU6227101A (en) Substituted iminoazines
IL155103A0 (en) Substituted c-cyclohexylmethylamine derivatives
IL155106A0 (en) Substituted 1-aminobutan-3-ol derivatives
IL150557A0 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives
AU5825501A (en) Substituted benzoylcyclohexenones
HK1052499A1 (zh) 氨基磺酰基聯苯基衍生物
IL150558A0 (en) Aminomethyl-phenyl-cyclohexanone derivatives
AU2163202A (en) 5-amino-1-pentene-3-ol substituted derivatives
EP1408955A4 (en) NEW METALLOTEXAPHYRINE DERIVATIVES
AU2360402A (en) Substituted phenyluracils
IL151598A0 (en) 2-phenylpyran-4-one derivatives
SI1246793T1 (sl) Substituirani aminometil-fenil-cikloheksanski derivati
SI1322590T1 (sl) Substituirani 5-amino-1-penten-3-olni derivati
HK1054937A1 (en) 1-Methylcarbapenem derivatives
GB0021639D0 (en) Maurotoxin derivatives